ZA200005923B - Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives. - Google Patents

Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives.

Info

Publication number
ZA200005923B
ZA200005923B ZA200005923A ZA200005923A ZA200005923B ZA 200005923 B ZA200005923 B ZA 200005923B ZA 200005923 A ZA200005923 A ZA 200005923A ZA 200005923 A ZA200005923 A ZA 200005923A ZA 200005923 B ZA200005923 B ZA 200005923B
Authority
ZA
South Africa
Prior art keywords
antibacterial agents
enhancement
oxazolidinone antibacterial
arginine derivatives
agents activity
Prior art date
Application number
ZA200005923A
Other languages
English (en)
Inventor
Michael John Bohanon
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA200005923B publication Critical patent/ZA200005923B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200005923A 1998-05-18 2000-10-23 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives. ZA200005923B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8116498A 1998-05-18 1998-05-18

Publications (1)

Publication Number Publication Date
ZA200005923B true ZA200005923B (en) 2001-10-23

Family

ID=22162494

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200005923A ZA200005923B (en) 1998-05-18 2000-10-23 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives.

Country Status (24)

Country Link
US (1) US6251869B1 (cs)
EP (1) EP1077718B1 (cs)
JP (1) JP2002515450A (cs)
KR (1) KR20010043695A (cs)
CN (1) CN1170584C (cs)
AT (1) ATE222115T1 (cs)
AU (1) AU746606B2 (cs)
BR (1) BR9910443A (cs)
CA (1) CA2327100A1 (cs)
CZ (1) CZ291945B6 (cs)
DE (1) DE69902526T2 (cs)
DK (1) DK1077718T3 (cs)
EA (1) EA003458B1 (cs)
ES (1) ES2182521T3 (cs)
HU (1) HUP0101958A3 (cs)
IL (1) IL139437A0 (cs)
NO (1) NO20005813D0 (cs)
NZ (1) NZ508256A (cs)
PL (1) PL344049A1 (cs)
PT (1) PT1077718E (cs)
SK (1) SK283038B6 (cs)
TR (1) TR200003384T2 (cs)
WO (1) WO1999059616A1 (cs)
ZA (1) ZA200005923B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US20050255538A1 (en) * 2002-03-15 2005-11-17 Buxser Stephen E Methods for screening for AcrAB efflux pump inhibitors
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
TW200607492A (en) * 2004-06-30 2006-03-01 Novartis Ag Method for increasing the susceptibility of peptide deformylase inhibitors by using efflux pump inhibitors
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
BRPI0616801B8 (pt) 2005-10-04 2021-05-25 Bayer Healthcare Ag "forma polimórfica de 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofenocarboxamida, seus processos de preparação e seus usos, medicamento, e processo para prevenção de coagulação de sangue in vitro
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
ES2970434T3 (es) 2014-09-12 2024-05-28 Union Therapeutics As Uso antibacteriano de salicilanilidas halogenadas
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
GB201604484D0 (en) 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
WO2020176067A1 (en) 2019-02-25 2020-09-03 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989832A (en) * 1995-04-21 1999-11-23 Microcide Pharmaceuticals, Inc. Method for screening for non-tetracycline efflux pump inhibitors
NZ502253A (en) * 1997-07-11 2001-06-29 Upjohn Co Thiadiazolyl and oxadiazolyl phenyl oxazolidinone derivatives which are antibacterial agents
US6068972A (en) * 1997-10-03 2000-05-30 Trustees Of Tufts College Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments

Also Published As

Publication number Publication date
HUP0101958A2 (hu) 2001-10-28
ATE222115T1 (de) 2002-08-15
AU746606B2 (en) 2002-05-02
NZ508256A (en) 2003-08-29
CZ291945B6 (cs) 2003-06-18
SK16252000A3 (sk) 2001-06-11
IL139437A0 (en) 2001-11-25
DK1077718T3 (da) 2002-11-11
EA200001197A1 (ru) 2001-04-23
CA2327100A1 (en) 1999-11-25
JP2002515450A (ja) 2002-05-28
SK283038B6 (sk) 2003-02-04
BR9910443A (pt) 2001-01-02
HUP0101958A3 (en) 2003-07-28
HK1036222A1 (en) 2001-12-28
DE69902526T2 (de) 2003-04-03
NO20005813L (no) 2000-11-17
PT1077718E (pt) 2002-12-31
DE69902526D1 (de) 2002-09-19
CN1297355A (zh) 2001-05-30
ES2182521T3 (es) 2003-03-01
EP1077718B1 (en) 2002-08-14
EA003458B1 (ru) 2003-06-26
CZ20004259A3 (en) 2001-05-16
EP1077718A1 (en) 2001-02-28
US6251869B1 (en) 2001-06-26
NO20005813D0 (no) 2000-11-17
PL344049A1 (en) 2001-09-24
CN1170584C (zh) 2004-10-13
WO1999059616A1 (en) 1999-11-25
KR20010043695A (ko) 2001-05-25
AU3860199A (en) 1999-12-06
TR200003384T2 (tr) 2001-03-21

Similar Documents

Publication Publication Date Title
ZA200005923B (en) Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives.
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
FI963232A0 (fi) Antimikrobisena aineena käytettävä hapotettu nitriitti
EA200400489A1 (ru) Препараты, содержащие цефалоспориновое соединение, и их применение в лечении бактериальных инфекций у кошек и собак
DE69831506D1 (en) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
AP2003002824A0 (en) Gyrase inhibitors and uses thereof
DE60042401D1 (de) Fab-i inhibitoren
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE60318826D1 (de) Alkoxypyridinderivate
BRPI0411534A (pt) derivados de lincomicina com atividade antimicrobiana
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
DE69615155D1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
DE69600244D1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
IL140768A0 (en) Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
EA200000697A1 (ru) ПРОИЗВОДНЫЕ БЕНЗО[C]ХИНОЛИЗИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ 5α-РЕДУКТАЗ
ATE225172T1 (de) Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
BRPI0411537A (pt) derivados de lincomicina que possuem atividade antibacteriana
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
EA200501830A1 (ru) Новые производные линкомицина, обладающие антимикробной активностью